Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The Director, Procurement will be responsible for managing the source to pay operations. The objective is to ensure Dyne is routinely sourcing and negotiating its external spend following a standard and efficient process. Initially, the role will be to create and manage a standard process with the help of a third-party managed service provider (MSP). Over time, the role will evolve to include any one or more of the following: integration of the sourcing process with internal systems (eg, Contracts, ERP, Visualization Softwares, etc.), administration of a procurement policy, management reporting and dashboards, and training.
This role is based in Waltham, MA without the possibility of being a remote role.
Primary Responsibilities Include:
- Establish and manage a standard sourcing and contract negotiations process
- Liaise with internal stakeholders to build and manage a pipeline of sourcing initiatives
- Own the relationship with the MSP, achieving high-quality service levels and internal stakeholder satisfaction
- Continuously improve the sourcing process to achieve industry standard return on investment
- Create and publish routinely a set of procurement metrics
- Provide training to the organization, as required
- Create and manage a procurement policy, including periodic auditing and compliance
- Manage subscriptions and software service providers, in partnership with IT
- Support Corporate Social Responsibility and external reporting obligations, as required
Education and Skills Requirements:
- Bachelor’s degree required
- At least 10 years purchasing/procurement experience in the biotech/pharma industry
- Experience with ERP / MRP / Procurement systems, processes and tools is a must
- Previous experience of working in a global business with matrix management
- Must be a self-starter and highly organized
- Excellent planning, interpersonal, and organizational skills
- Ability to develop accurate and timely reports, presentations and metrics
#LI-Onsite
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
This description is not intended to be constructed as an exhaustive list of duties, responsibilities, or requirements for the position. This position may change or assume additional duties at any time. The employee may be requested to perform different or additional duties as assigned. All Employees are expected to adhere to all company policies and act as a role model for company values.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Top Skills
What We Do
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
